Blend Labs officer sells 5,625 shares at $1.57

Blend Labs, Inc. principal accounting officer Oxana Tkach reported an open-market sale of Class A Common Stock.

Rhea-AI Filing Summary

Blend Labs, Inc. principal accounting officer Oxana Tkach reported an open-market sale of Class A Common Stock. She sold 5,625 shares at a price of $1.57 per share and held 117,447 shares of Class A Common Stock directly after the transaction.

The filing notes that this sale was effected under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, indicating it was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 5,625 shares

Net Sell 1 txn

Insider Tkach Oxana

Role PRINCIPAL ACCOUNTING OFFICER

Sold 5,625 shs ($9K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	5,625	$1.57	$9K

Holdings After Transaction: Class A Common Stock — 117,447 shares (Direct)

Footnotes (1)

1. F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025.

Key Figures

Shares sold: 5,625 shares Sale price: $1.57 per share Shares held after transaction: 117,447 shares +2 more

5 metrics

Shares sold 5,625 shares Open-market sale of Class A Common Stock

Sale price $1.57 per share Price for the 5,625 shares sold

Shares held after transaction 117,447 shares Direct holdings of Class A Common Stock after sale

Transaction date May 22, 2026 Date of reported open-market sale

Transaction code S Sale in open market or private transaction

Key Terms

Class A Common Stock, open-market sale, Rule 10b5-1 trading plan, principal accounting officer

4 terms

Class A Common Stock financial

"security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Rule 10b5-1 trading plan financial

"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

principal accounting officer financial

"officer_title: PRINCIPAL ACCOUNTING OFFICER"

The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Blend Labs (BLND) report in this Form 4?

Blend Labs reported that principal accounting officer Oxana Tkach sold 5,625 shares of Class A Common Stock at $1.57 per share. The transaction was an open-market sale and was executed under a pre-arranged Rule 10b5-1 trading plan.

Who is the insider involved in the latest Blend Labs (BLND) Form 4 filing?

The insider is Oxana Tkach, the principal accounting officer of Blend Labs, Inc. She reported an open-market sale of Class A Common Stock and remained a significant shareholder with 117,447 shares directly owned after the reported transaction.

How many Blend Labs (BLND) shares does Oxana Tkach hold after the sale?

After selling 5,625 shares of Class A Common Stock, Oxana Tkach directly holds 117,447 shares. This figure reflects her post-transaction ownership reported in the Form 4 and provides context for the relative size of the sale.

At what price were the Blend Labs (BLND) shares sold in the Form 4 transaction?

The reported transaction shows that 5,625 shares of Blend Labs Class A Common Stock were sold at $1.57 per share. This sale price reflects the open-market transaction value disclosed for the shares involved in the Form 4 filing.

Was the Blend Labs (BLND) insider sale under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, indicating the timing of this sale was set in advance rather than chosen opportunistically.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tkach Oxana

(Last) (First) (Middle)

7250 REDWOOD BLVD., SUITE 300

(Street)

NOVATO CALIFORNIA 94945

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRINCIPAL ACCOUNTING OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/22/2026		S(1)		5,625	D	$1.57	117,447	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2025.

	/s/ Kostian Ciko, Attorney-in-fact	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)